Investor Overview

Press Release

<< Back
01/11/16
Presentation Materials for Orthofix's Upcoming Conference Presentation

LEWISVILLE, Texas--(BUSINESS WIRE)-- As previously announced, Orthofix International N.V. (NASDAQ:OFIX), a diversified, global medical device company, will be presenting on Thursday, January 14, 2016 at the 34th Annual J.P. Morgan Healthcare Conference. President and Chief Executive Officer Brad Mason will represent the Company in a presentation scheduled for 8:00 a.m. Pacific Time. A live audio webcast will be available on the Company's website at www.orthofix.com by clicking on the Investors tab and then clicking the link on the Events and Presentations page.

The Company will be releasing written materials and other information, including preliminary guidance regarding anticipated 2016 financial performance, in connection with its presentation at approximately 4:00 p.m. Eastern Time on Tuesday, January 12, 2016. Such materials will be available at http://ir.orthofix.com/events.cfm.

About Orthofix

Orthofix International N.V. is a diversified, global medical device company focused on improving patients' lives by providing superior reconstructive and regenerative orthopedic and spine solutions to physicians worldwide. Headquartered in Lewisville, Texas, the Company has four strategic business units that include BioStim, Biologics, Extremity Fixation and Spine Fixation. Orthofix products are widely distributed via the Company's sales representatives, distributors and its subsidiaries. In addition, Orthofix is collaborating on research and development activities with leading clinical organizations such as the Musculoskeletal Transplant Foundation and the Texas Scottish Rite Hospital for Children. For more information, please visit www.orthofix.com.

Orthofix International N.V.
Mark Quick, 214-937-2924
markquick@orthofix.com
or
Denise Landry, 214-937-2529
deniselandry@orthofix.com

Source: Orthofix International N.V.

News Provided by Acquire Media